AMNAMN HEALTHCARE SERVICES INC(AMN)Stock Analysis

AI analysis on 6,000+ stocks →
IndustrialsNYSE
Institutional-grade research for retail investors
SEC EDGAR: CIK 1142750AMN stock profile & AI dashboard →

13F Pro Quality Score

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

17.3/100

Profitability

28.6/100

Balance Sheet

31.5/100

AMN Stock Analysis & AI Quality Score

AI stock analysis and institutional research for AMN HEALTHCARE SERVICES INC (AMN), a Industrials sector company. 13F Pro's AI-powered ranking engine scores AMN at 44.3/100 on a 32-signal composite quality model, placing it at rank #1,771 of 2,849 stocks — the bottom half of the AI-ranked universe. AMN scores in the top quartile across free cash flow (79.8). Areas of concern include revenue growth (17.3) and profitability (28.6), which score below median versus the broader universe. Based on the latest XBRL financial filings, AMN HEALTHCARE SERVICES INC reports trailing revenue of $1.4B, net income of $62.2M, free cash flow of $555.2M. Top institutional holders of AMN by reported 13-F value include Creative Planning, Creative Planning, Focus Partners Wealth, based on the most recent SEC filings. AMN trades on the NYSE exchange and files with the SEC under CIK 1142750. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AMN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AMN HEALTHCARE SERVICES INC directly from SEC EDGAR.

Revenue

Q1 2026

$1.4B

Net Income

Q1 2026

$62.2M

Free Cash Flow

Q1 2026

$555.2M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-8.5% YoY
$2.73BFY 2025
FY22 $5.24BFY23 $3.79BFY24 $2.98BFY25 $2.73B

Net Income

+34.9% YoY
$-95.7MFY 2025
FY22 $444.1MFY23 $210.7MFY24 $-147.0MFY25 $-95.7M

Operating Income

+46.0% YoY
$-55.5MFY 2025
FY22 $647.1MFY23 $338.4MFY24 $-102.7MFY25 $-55.5M

EPS (Diluted)

+35.6% YoY
$-2.48FY 2025
FY22 $9.90FY23 $5.36FY24 $-3.85FY25 $-2.48

Total Assets

-13.3% YoY
$2.09BFY 2025
FY22 $2.89BFY23 $2.92BFY24 $2.42BFY25 $2.09B

Total Debt

-27.4% YoY
$767.1MFY 2025
FY22 $843.5MFY23 $1.30BFY24 $1.06BFY25 $767.1M

Op. Cash Flow

-15.9% YoY
$269.5MFY 2025
FY22 $653.7MFY23 $372.2MFY24 $320.4MFY25 $269.5M

Track AMN with AI-powered research

10 AI analysts debate this stock daily. Free to start.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for AMN HEALTHCARE SERVICES INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of AMN

Unlock Full Research for AMN

Get detailed financial analysis, insider activity, institutional flows, AI-powered debates, and quality rankings for AMN HEALTHCARE SERVICES INC and 6,000+ other companies.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is AMN a good stock to buy?

13F Pro's AI-powered analysis of AMN HEALTHCARE SERVICES INC (AMN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AMN are available on the AMN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own AMN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AMN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of AMN HEALTHCARE SERVICES INC's investment landscape.